Multicenter study of combination therapy using mizoribine, cyclosporin, basiliximab and steroids in kidney transplantation.
Not Applicable
- Conditions
- Kidney transplantation
- Registration Number
- JPRN-UMIN000000732
- Lead Sponsor
- MNKT Forum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
1.The patient who has a history of hypersensitivity against components of either one of the following drugs: Bredinin tablet, Neoral or Simulect. 2.The patient who is pregnant or a female patient who is expecting to become pregnant. 3.The patients who showed a positive result with cross match test. 4.The patient who recived ABO incompatible donor. 5.The patient with whom the physician-in-charge considered inappropriate as a subject of this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method